| Sbk Medical Consulting Inc | |
|
1441 Kapiolani Blvd Ste 606 Honolulu HI 96814-4403 | |
| (808) 951-9931 | |
| Not Available |
| Full Name | Sbk Medical Consulting Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 1441 Kapiolani Blvd Ste 606, Honolulu, Hawaii |
| Authorized Official Name and Position | Simon B Kim (OWNER) |
| Authorized Official Contact | 8089519931 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Sbk Medical Consulting Inc Po Box 25370 Honolulu HI 96825-0370 Ph: (808) 536-0300 | Sbk Medical Consulting Inc 1441 Kapiolani Blvd Ste 606 Honolulu HI 96814-4403 Ph: (808) 951-9931 |
| NPI Number | 1003054081 |
|---|---|
| Provider Enumeration Date | 01/28/2009 |
| Last Update Date | 01/28/2009 |
| Medicare PECOS PAC ID | 3476601808 |
|---|---|
| Medicare Enrollment ID | O20090423000229 |
News Archive
University of Rochester scientists studying a vital protein called Serum Response Factor (SRF) in mice have learned new and unexpected facts about SRF's role in early cardiovascular development, and how a defect in this gene may be an underlying cause in human miscarriages.
The routine use of the glycosylated hemoglobin test to track blood sugar levels in the general population can identify individuals with more advanced atherosclerotic disease.
Making it easier to obtain emergency contraception would not increase unprotected intercourse, lead to abandonment of regular contraception, or increase the risk of sexually transmitted infections (STIs), according to a study in the January 5 issue of JAMA.
Women are under-represented in academic medicine resulting in a waste of public investment due to loss of research talent. Writing in the July issue of the Journal of the Royal Society of Medicine, authors of an essay on women and academic medicine say that as a consequence of female under-representation, some areas of medicine are under-researched at a cost to patients and society.
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003054081 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 13022 (Hawaii) | Primary |
| Provider Name | Simon B Kim |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1194792333 PECOS PAC ID: 5597798736 Enrollment ID: I20050916000933 |
News Archive
University of Rochester scientists studying a vital protein called Serum Response Factor (SRF) in mice have learned new and unexpected facts about SRF's role in early cardiovascular development, and how a defect in this gene may be an underlying cause in human miscarriages.
The routine use of the glycosylated hemoglobin test to track blood sugar levels in the general population can identify individuals with more advanced atherosclerotic disease.
Making it easier to obtain emergency contraception would not increase unprotected intercourse, lead to abandonment of regular contraception, or increase the risk of sexually transmitted infections (STIs), according to a study in the January 5 issue of JAMA.
Women are under-represented in academic medicine resulting in a waste of public investment due to loss of research talent. Writing in the July issue of the Journal of the Royal Society of Medicine, authors of an essay on women and academic medicine say that as a consequence of female under-representation, some areas of medicine are under-researched at a cost to patients and society.
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
› Verified 9 days ago
News Archive
University of Rochester scientists studying a vital protein called Serum Response Factor (SRF) in mice have learned new and unexpected facts about SRF's role in early cardiovascular development, and how a defect in this gene may be an underlying cause in human miscarriages.
The routine use of the glycosylated hemoglobin test to track blood sugar levels in the general population can identify individuals with more advanced atherosclerotic disease.
Making it easier to obtain emergency contraception would not increase unprotected intercourse, lead to abandonment of regular contraception, or increase the risk of sexually transmitted infections (STIs), according to a study in the January 5 issue of JAMA.
Women are under-represented in academic medicine resulting in a waste of public investment due to loss of research talent. Writing in the July issue of the Journal of the Royal Society of Medicine, authors of an essay on women and academic medicine say that as a consequence of female under-representation, some areas of medicine are under-researched at a cost to patients and society.
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
› Verified 9 days ago
Emily Diep, M.d., Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 321 N Kuakini St, Suite Number 715, Honolulu, HI 96817 Phone: 808-523-6461 Fax: 808-550-0466 | |
Restoration Health Care Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 828 18th Ave, Honolulu, HI 96816 Phone: 808-892-7571 | |
Central Medical Clinic Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 321 N. Kuakini St., Suite #201, Honolulu, HI 96817 Phone: 808-523-8611 | |
Frederick Fong Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1380 Lustiana Street, Suite 514, Honolulu, HI 96813 Phone: 808-531-7551 Fax: 808-537-3652 | |
Dr Jin Kim Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2851 E Manoa Rd Ste 1-205, Honolulu, HI 96822 Phone: 808-988-6113 | |
Mahalo Doctor Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1301 Punchbowl St, Honolulu, HI 96813 Phone: 415-314-0699 |